Overview of recommendations on the use of real-time continuous glucose monitoring (rtCGM) and hybrid closed-loop technology for people with diabetes
Adults
NICE recommends offering rtCGM or isCGM to all adults with type 1 diabetes.*,1
Adults with type 2
NICE recommends considering rtCGM as an alternative to isCGM if available for the same or lower cost.*,2
Children and young people
Type 1 diabetes: NICE recommends rtCGM for all children aged 2+.*,3
Type 2 diabetes: NICE recommends rtCGM for children who cannot use BGM or need to finger prick 8+ times a day and/or exhibit recurrent/severe hypoglycaemia.*,3
Pregnancy
NICE recommends offering rtCGM to all pregnant women with type 1 diabetes.*,4
Hybrid closed-loop (HCL) systems, the Dexcom way
NICE recommends HCL (rtCGM with a connected insulin pump†) as an option for managing glucose, for all people with type 1 diabetes meeting any of the following criteria:*,5
- Age 18 or under with type 1 diabetes
- Over 18 with HbA1c >7.5%
- Suffers from disabling hypoglycaemia
- Women who are pregnant or trying to conceive a baby
How to access rtCGM for your patients
Dexcom rtCGM Systems are now on formulary and can be prescribed in widespread locations throughout the UK.‡
For further information on prescribing rtCGM for your patients, please contact our dedicated market access team.
Choosing a CGM system
NICE guidelines recommend shared decision-making to support the choice of CGM system, and provide criteria to consider.*,1–5
The portfolio of Dexcom rtCGM Systems is designed to meet all the NICE-recommended criteria, depending on the needs and preferences of each patient.
See the full guidelines
Recommending the right fit for each patient
Discover the ideal Dexcom rtCGM System for each individual in your care.
Dexcom ONE
Best for people type 1 or type 2 diabetes who need a smart, easy and effective rtCGM system.
Dexcom G series
Best for people with type 1 diabetes who may need extra support, such as people who are hypo unaware, pregnant or children, and those that want connectivity with insulin delivery systems and health or lifestyle apps.
Keeping up to date with the latest recommendations
Help ensure you and your colleagues are comfortable with the latest guidance and best practice regarding diabetes technology in the care of people with diabetes.
By registering for Dexcom Education Hub, you’ll find CPD-accredited and practical education on CGM and its integration with insulin pumps and other connected technology, interpreting patient data, clinical evidence, and more.
*© NICE [2023]. All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.
†Compatible insulin-delivery devices sold separately. For a list of compatible devices, please visit www.dexcom.com/compatibility.
‡Dexcom ONE is available on prescription (FP10). Formulary approval of Dexcom rtCGM Systems can vary in different parts of the UK.
1 Type 1 diabetes in adults: diagnosis and management NICE guideline [NG17].
2 Type 2 diabetes in adults: management NICE guideline [NG28].
3 Diabetes (type 1 and type 2) in children and young people: diagnosis and management NICE guideline [NG18].
4 Diabetes in pregnancy: management from preconception to the postnatal period. NICE guideline [NG3].
5 Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes [TA10845] (see https://www.nice.org.uk/guidance/indevelopment/gid-ta10845).